Publication:
Changes in plasma fatty acid composition are associated with improvements in obesity and related metabolic disorders: A therapeutic approach to overweight adolescents.

dc.contributor.authorGuerendiain, Marcela
dc.contributor.authorMontes, Rosa
dc.contributor.authorLópez-Belmonte, Gemma
dc.contributor.authorMartín-Matillas, Miguel
dc.contributor.authorCastellote, Ana I
dc.contributor.authorMartín-Bautista, Elena
dc.contributor.authorMartí, Amelia
dc.contributor.authorMartínez, J Alfredo
dc.contributor.authorMoreno, Luis
dc.contributor.authorGaragorri, Jesús Mª
dc.contributor.authorWärnberg, Julia
dc.contributor.authorCaballero, Javier
dc.contributor.authorMarcos, Ascensión
dc.contributor.authorLópez-Sabater, M Carmen
dc.contributor.authorCampoy, Cristina
dc.contributor.authorEVASYON Study Group
dc.date.accessioned2023-01-25T09:42:28Z
dc.date.available2023-01-25T09:42:28Z
dc.date.issued2016-11-11
dc.description.abstractIn recent years, obesity has reached alarming levels among children and adolescents. The study of plasma fatty acid (FA) composition, as a reflection of diet, and its associations with other parameters, that are closely linked to obesity and the cardiometabolic profile, may be useful for setting nutritional goals for obesity treatment and prevention. This study explored the relationship between plasma FA levels and body fat and cardiometabolic risk markers, in overweight adolescents. A multidisciplinary weight loss program was followed by 127 overweight and obese adolescents aged 12-17 years old. Plasma FA composition, anthropometric indicators of adiposity and biochemical parameters were analyzed at baseline, two months (the end of the intensive intervention phase) and six months (the end of the extensive phase). While saturated fatty acid (SFA) and n-6 polyunsaturated fatty acid (PUFA) levels decreased significantly during the intervention, monounsaturated fatty acid (MUFA) and n-3 PUFA showed the opposite trend. The decrease in SFA C14:0 was associated with a reduction in total and LDL cholesterol, apolipoprotein B and insulin. The increase in MUFAs, especially C18:1n-9, was related to a reduction in weight, fat mass, fat mass index and glucose. Regarding PUFAs, changes in the n-3 series were not associated with any of the parameters studied, whereas the reduction in n-6 PUFAs was directly related to weight, fat mass, total and HDL cholesterol, apolipoprotein A1, glucose and insulin, and inversely associated with diastolic blood pressure. The adolescents with greater weight loss presented significant changes in MUFAs, n-6 PUFAs and C14:0. Modifications in plasma FA composition were associated with adiposity reduction and cardiometabolic profile improvement in an anti-obesity program aimed at adolescents. The changes observed in FA composition were related to the success of the treatment, since the individuals most affected by these variations were those who presented the greatest weight loss.
dc.identifier.doi10.1016/j.clnu.2016.11.006
dc.identifier.essn1532-1983
dc.identifier.pmid27887752
dc.identifier.unpaywallURLhttps://zaguan.unizar.es/record/75645/files/texto_completo.pdf
dc.identifier.urihttp://hdl.handle.net/10668/10639
dc.issue.number1
dc.journal.titleClinical nutrition (Edinburgh, Scotland)
dc.journal.titleabbreviationClin Nutr
dc.language.isoen
dc.organizationHospital Universitario Reina Sofía
dc.page.number149-156
dc.pubmedtypeJournal Article
dc.pubmedtypeResearch Support, Non-U.S. Gov't
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectAdiposity
dc.subjectCardiometabolic profile
dc.subjectObese adolescents
dc.subjectPlasma fatty acids
dc.subjectWeight loss
dc.subject.meshAdolescent
dc.subject.meshChild
dc.subject.meshFatty Acids
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshMale
dc.subject.meshObesity
dc.subject.meshWeight Loss
dc.subject.meshWeight Reduction Programs
dc.titleChanges in plasma fatty acid composition are associated with improvements in obesity and related metabolic disorders: A therapeutic approach to overweight adolescents.
dc.typeresearch article
dc.type.hasVersionAM
dc.volume.number37
dspace.entity.typePublication

Files